518 related articles for article (PubMed ID: 18830669)
41. Pathologic prognostic factors in Barrett's associated adenocarcinoma: a follow-up study of 96 patients.
Torres C; Turner JR; Wang HH; Richards W; Sugarbaker D; Shahsafaei A; Odze RD
Cancer; 1999 Feb; 85(3):520-8. PubMed ID: 10091725
[TBL] [Abstract][Full Text] [Related]
42. Appraisal of a revised lymph node classification system for esophageal squamous cell cancer.
Dhar DK; Hattori S; Tonomoto Y; Shimoda T; Kato H; Tachibana M; Matsuura K; Mitsumoto Y; Little AG; Nagasue N
Ann Thorac Surg; 2007 Apr; 83(4):1265-72. PubMed ID: 17383324
[TBL] [Abstract][Full Text] [Related]
43. An evaluation of the number of lymph nodes examined and survival for node-negative esophageal carcinoma: data from China.
Yang HX; Xu Y; Fu JH; Wang JY; Lin P; Rong TH
Ann Surg Oncol; 2010 Jul; 17(7):1901-11. PubMed ID: 20146101
[TBL] [Abstract][Full Text] [Related]
44. Prognostic factors of curatively resected esophageal carcinoma associated with multiple metastatic lymph nodes.
Tabira Y; Sakaguchi T; Yoshida Y; Kuhara H; Kawasuji M
Hepatogastroenterology; 2006; 53(71):715-9. PubMed ID: 17086875
[TBL] [Abstract][Full Text] [Related]
45. Prognostic factors and family history for survival of esophageal squamous cell carcinoma patients after surgery.
Yuequan J; Shifeng C; Bing Z
Ann Thorac Surg; 2010 Sep; 90(3):908-13. PubMed ID: 20732516
[TBL] [Abstract][Full Text] [Related]
46. Survival after esophageal resection for carcinoma: the importance of the histologic cell type.
Alexiou C; Khan OA; Black E; Field ML; Onyeaka P; Beggs L; Duffy JP; Beggs DF
Ann Thorac Surg; 2006 Sep; 82(3):1073-7. PubMed ID: 16928541
[TBL] [Abstract][Full Text] [Related]
47. [Surgical therapy of esophageal cancer--early results].
Hildebrandt J; Nürnberger H; Lehner J; Löhlein D
Med Klin (Munich); 1994 Sep; 89(9):459-63. PubMed ID: 7968879
[TBL] [Abstract][Full Text] [Related]
48. Do tumor grade and location affect survival in esophageal squamous cell carcinoma? Survival analysis of 302 cases of pT3N0M0 esophageal squamous cell carcinoma.
Situ D; Wei W; Lin P; Long H; Zhang L; Fu J; Rong T; Ma G
Ann Surg Oncol; 2013 Feb; 20(2):580-5. PubMed ID: 23015029
[TBL] [Abstract][Full Text] [Related]
49. Outcome of low-volume surgery for esophageal cancer in a high-volume referral center.
Courrech Staal EF; van Coevorden F; Cats A; Aleman BM; van Velthuysen ML; Boot H; Peeters MJ; van Sandick JW
Ann Surg Oncol; 2009 Dec; 16(12):3219-26. PubMed ID: 19777184
[TBL] [Abstract][Full Text] [Related]
50. A second malignancy is the major cause of death among thoracic squamous cell esophageal cancer patients negative for lymph node involvement.
Sato Y; Motoyama S; Maruyama K; Okuyama M; Ogawa J
J Am Coll Surg; 2005 Aug; 201(2):188-93. PubMed ID: 16038814
[TBL] [Abstract][Full Text] [Related]
51. Pretreatment T3-4 stage is an adverse prognostic factor in patients with esophageal squamous cell carcinoma who achieve pathological complete response following preoperative chemoradiotherapy.
Chao YK; Chan SC; Liu YH; Chen HW; Wan YL; Chang HK; Fan KH; Liu HP
Ann Surg; 2009 Mar; 249(3):392-6. PubMed ID: 19247024
[TBL] [Abstract][Full Text] [Related]
52. [Prognostic analysis of clinicopathological factors in patients after radical resection of esophageal carcinoma].
Zhu SC; Song CL; Shen WB; Su JW; Li J; Liu ZK
Zhonghua Zhong Liu Za Zhi; 2012 Apr; 34(4):281-6. PubMed ID: 22781041
[TBL] [Abstract][Full Text] [Related]
53. Clinicopathologic features of superficial esophageal cancer: results of consecutive 100 patients.
Tachibana M; Hirahara N; Kinugasa S; Yoshimura H
Ann Surg Oncol; 2008 Jan; 15(1):104-16. PubMed ID: 17891442
[TBL] [Abstract][Full Text] [Related]
54. Refining esophageal cancer staging.
Rice TW; Blackstone EH; Rybicki LA; Adelstein DJ; Murthy SC; DeCamp MM; Goldblum JR
J Thorac Cardiovasc Surg; 2003 May; 125(5):1103-13. PubMed ID: 12771884
[TBL] [Abstract][Full Text] [Related]
55. An audit of surgical outcomes of esophageal squamous cell carcinoma.
Goan YG; Chang HC; Hsu HK; Chou YP
Eur J Cardiothorac Surg; 2007 Mar; 31(3):536-44. PubMed ID: 17222561
[TBL] [Abstract][Full Text] [Related]
56. Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): impact of adequate staging on outcome.
Barbour AP; Rizk NP; Gonen M; Tang L; Bains MS; Rusch VW; Coit DG; Brennan MF
Ann Surg Oncol; 2007 Feb; 14(2):306-16. PubMed ID: 17091329
[TBL] [Abstract][Full Text] [Related]
57. [Critical analysis of the new TNM staging (UICC, 1987) of cancer of the cervical esophagus in relation to therapeutic decisions].
Peracchia A; Ruol A; Narne S; Tiso E; Segalin A; Lazzaro S; Anselmino M; Bardini R
Acta Otorhinolaryngol Ital; 1990; 10(3):275-85. PubMed ID: 1704170
[TBL] [Abstract][Full Text] [Related]
58. Neoadjuvant chemotherapy and surgery for esophageal adenocarcinoma: prognostic value of circumferential resection margin and stratification of N1 category.
Saha AK; Sutton C; Rotimi O; Dexter S; Sue-Ling H; Sarela AI
Ann Surg Oncol; 2009 May; 16(5):1364-70. PubMed ID: 19252949
[TBL] [Abstract][Full Text] [Related]
59. Assessment of criteria and clinical significance of circumferential resection margins in esophageal cancer.
Deeter M; Dorer R; Kuppusamy MK; Koehler RP; Low DE
Arch Surg; 2009 Jul; 144(7):618-24. PubMed ID: 19620541
[TBL] [Abstract][Full Text] [Related]
60. Surgical treatment for carcinoma of the esophagus in the elderly patient.
Xijiang Z; Xizeng Z; Xishan H; Hongjing J
Ann Thorac Cardiovasc Surg; 1999 Jun; 5(3):182-6. PubMed ID: 10413765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
